Fecal microbiota transplantation for ulcerative colitis-where to from here?
- PMID: 31304425
- PMCID: PMC6624363
- DOI: 10.21037/tgh.2019.06.04
Fecal microbiota transplantation for ulcerative colitis-where to from here?
Conflict of interest statement
Conflicts of Interest: Thomas J. Borody has a pecuniary interest in the Centre for Digestive Diseases and has filed patents in fecal microbiota therapies. He also holds a gratis advisory board position with Finch Therapeutics. The other author has no conflicts of interest to declare.
Comment on
-
Effect of Fecal Microbiota Transplantation on 8-Week Remission in Patients With Ulcerative Colitis: A Randomized Clinical Trial.JAMA. 2019 Jan 15;321(2):156-164. doi: 10.1001/jama.2018.20046. JAMA. 2019. PMID: 30644982 Free PMC article. Clinical Trial.
References
Publication types
LinkOut - more resources
Full Text Sources